Labcorp Growth Push Meets Cost and Reimbursement Risks
Specialty testing, acquisitions and margin gains support expansion, while higher costs and reimbursement changes remain risks.
Makkler Newsroom · Sep 29, 04:07 PM · 1 min read
Market open· · USD · Data may be delayed
Avg. target $392.93 (+6.0%)
Prices may be delayed and are for informational purposes only - not investment advice.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.